.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

UBS
Fuji
Medtronic
Dow
Chinese Patent Office
Johnson and Johnson
Daiichi Sankyo
US Army
Express Scripts
Cerilliant

Generated: September 19, 2017

DrugPatentWatch Database Preview

NADOLOL AND BENDROFLUMETHIAZIDE Drug Profile

« Back to Dashboard

What is the patent landscape for Nadolol And Bendroflumethiazide, and what generic Nadolol And Bendroflumethiazide alternatives are available?

Nadolol And Bendroflumethiazide is a drug marketed by Impax Labs and Mylan and is included in two NDAs.

The generic ingredient in NADOLOL AND BENDROFLUMETHIAZIDE is bendroflumethiazide; nadolol. There are four drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the bendroflumethiazide; nadolol profile page.

Summary for Tradename: NADOLOL AND BENDROFLUMETHIAZIDE

Patents:0
Applicants:2
NDAs:2
Suppliers / Packagers: see list1
Bulk Api Vendors: see list1
Clinical Trials: see list106,451
Patent Applications: see list1
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:NADOLOL AND BENDROFLUMETHIAZIDE at DailyMed

Pharmacology for Tradename: NADOLOL AND BENDROFLUMETHIAZIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Impax Labs
NADOLOL AND BENDROFLUMETHIAZIDE
bendroflumethiazide; nadolol
TABLET;ORAL077833-001Mar 30, 2007ABRXNoNo► Subscribe► Subscribe► Subscribe
Mylan
NADOLOL AND BENDROFLUMETHIAZIDE
bendroflumethiazide; nadolol
TABLET;ORAL078688-002Feb 15, 2008ABRXNoNo► Subscribe► Subscribe► Subscribe
Impax Labs
NADOLOL AND BENDROFLUMETHIAZIDE
bendroflumethiazide; nadolol
TABLET;ORAL077833-002Mar 30, 2007ABRXNoNo► Subscribe► Subscribe► Subscribe
Mylan
NADOLOL AND BENDROFLUMETHIAZIDE
bendroflumethiazide; nadolol
TABLET;ORAL078688-001Feb 15, 2008ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Fuji
Accenture
Medtronic
Chinese Patent Office
Julphar
Cipla
Dow
Teva
Express Scripts
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot